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Abstract: Transplantation Surgery has undergone a great development during the last thirty years and the survival of solid 
organ recipients has increased dramatically. Osteo-articular diseases such as osteoporosis, fractures, avascular bone 
necrosis and osteoarthritis are relatively common in these patients and joint arthroplasty may be required. The outcome of 
hip arthroplasty in patients with osteonecrosis of the femoral head after renal transplantation has been studied and 
documented by many researchers. However, the results of joint arthroplasties other than the hip in solid organs recipients 
were only infrequently reported in the literature. A systematic review of the English literature was conducted in order to 
investigate the outcome of joint arthroplasties other than the hip in kidney, liver or heart transplant recipients. Nine 
pertinent articles including 51 knee arthroplasties, 8 shoulder arthroplasties and 1 ankle arthroplasty were found. These 
articles reported well to excellent results with a complication rate and spectrum comparable with those reported in non-
transplant patients. 
Keywords: Joint arthroplasty, solid organ transplant, immunosuppression, outcome, complication. 
INTRODUCTION 
  Solid organ transplantation such as kidney, liver, heart 
and lung has become the method of choice in treating 
patients with end-stage failure of these organs. Annually, 
more than 12000 kidney transplantations, 5000 liver 
transplantations and 2000 heart transplantations are 
performed in the United States. The overall long-term 
survival has apparently improved despite coexisting 
morbidities, old age and high BMI of the operated patients, 
higher degree of HLA mismatch and long waiting time [1-7]. 
This improvement is mainly due to the advancement in 
careful patient selection, perioperative care, surgical 
technique and immunosuppressive drugs. However, these 
patients have increased risk to develop infections and 
malignancies caused by the required life-long 
immunosuppressive therapy. Furthermore, the metabolic 
derangement associated with preoperative renal or hepatic 
failure as well as post-transplant medications commonly give 
rise to bone diseases such as osteopenia/osteoporosis, 
fractures, avascular bone necrosis (AVN) and bone pain. 
Some of these patients require joint arthroplasty. As the 
success rate of solid organ transplantation continues to rise, 
more patients will become candidate to joint replacement 
surgery. However, concerns still exist regarding the 
vulnerability of these patients to certain complications such 
as postoperative infection due to chronic immunosuppression 
and mechanical implant failure due to poor bone quality. 
  The results of total hip replacement in renal transplant 
recipient with AVN of the femoral head were thoroughly 
discussed by Nowicki and Chaudhary [8]. Their review of 
literature showed that cemented hip replacement provided   
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good to excellent outcome without significant increment of 
postoperative infection. The rate of mechanical implant 
failure was found to be high in young patients and in patients 
with decreased bony stock. However, porous-coated 
prostheses were not found to be contra-indicated. 
  In order to complete the evaluation of the outcome of 
joint replacement in transplant recipient, We reviewed the 
literature to study the results of joint replacement surgeries 
other than the hip in solid organ transplant recipients. We 
found only few works with markedly few patients. 
  This might raise the importance of this review article as it 
assembles the results of these few works so as to give a 
clearer picture about the outcome of these surgeries. 
IMMUNOSUPPRESSIVE THERAPY IN SOLID 
ORGAN TRANSPLANT RECIPIENTS 
  Corticosteroids are still considered as first line 
armamentarium in the post-transplant immunosuppression. 
Both high daily doses and pulse doses may be contributed to 
the high incidence of side effects encountered with these 
agents. The introduction of Azathioprin, which is a purin 
synthesis inhibitor, and Cyclosporin A, which is a potent 
cytotoxic T-cells inhibitor, in early 1980s minimized the 
need for high corticosteroid doses and improved the overall 
graft survival reducing the rejection rate. Further 
advancement was achieved by the discovery and the use of 
agents such as Tacrolimus which inhibits T-lymphocyte 
signal transduction and interleukin-2 transcription, and 
Sirolimus which inhibits the response to interleukin-2 
thereby blocking the activation of T- and B-cells. 
OSTEO-ARTICULAR DISEASES IN SOLID ORGAN 
TRANSPLANT RECIPIENTS 
  Osteo-articular diseases are common in solid organ 
transplant recipients [9, 10]. The underlying patho-
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failure, for example, have multi-factorial metabolic bone 
disease already prior to the transplantation. 
  Renal osteodystrophy caused by phosphate loss with 
subsequent hypercalcaemia and hyperparathyroidism is 
associated with defective mineralization. Vitamin D 
metabolism is adversely affected in hepatic failure while 
bone formation is diminished secondary to 
hyperbilirubinemia and malnutrition. On the other side, 
acidosis and hypogonadism give rise to high bone turn over. 
In cardiac failure patients, biomarkers of bone formation and 
Vitamin D metabolites are lower than in controls while the 
biomarker of bone resorption is higher [11]. 
  After transplantation, several factors contribute to osteo-
articular diseases. Pre-exciting metabolic bone disease, low 
BMI and muscle mass, postoperative malnutrition and 
inactivity as well as the immunosuppressive therapy such as 
high doses of corticosteroids may all lead to poor bone 
quality and increased fracture risk [9, 12-14]. Moreover, 
AVN was reported to take place in 3% to 41% of renal 
transplant recipients [15], up to 9% of liver transplant 
recipients and 3% of cardiac transplant recipient [16, 17]. 
MATERIAL AND METHODS 
  To address the outlined issue of joint arthroplasties other 
than the hip in solid organ transplant recipients, we 
conducted a systematic review of the PubMed (National 
Library of Medicine and National Institute of Health, USA), 
Cochrane library and EMBASE archives. We searched for 
full text articles in English published between 1980 and 2008 
using combinations and variations of the following terms: 
joint replacement/ arthroplasty, organ transplantation, 
kidney/renal, liver/hepatic, heart/cardiac, outcome and 
complications. A manual reference check of all retrieved 
papers and recent reviews was performed to supplement the 
electronic searches and to identify any additional potentially 
relevant studies. 
  Due to the small number of the articles found we chose to 
include all the papers dealing with the results of joint 
arthroplasties in solid organ (kidney, liver, heart) transplant 
recipients regardless of study design, sample size or duration 
of follow-up. 
RESULTS 
  The review revealed 9 pertinent studies that met the 
criteria of inclusion. These included 51 knee arthroplasties, 8 
shoulder arthroplasties and 1 ankle arthroplasty. The mean 
age of patients at the time of arthroplasty operation was 49 
years (16-79). The mean time between the transplantation 
operation and the arthroplasty surgery was 77 months (6-
294) and the mean follow up period for the arthroplasty 
operations was 60 months (3-202). Follow up was carried 
out using different outcome indexes, clinical examinations 
and records concerning the occurrence of various 
complications. Radiographs were taken whenever indicated 
to verify the status of the prosthesis examined. All of the 
included papers reported good to excellent functional 
outcome. One paper revealed major complications, one of 
which gave a fatal outcome, while others reported no or 
minor complications without any drawback of the functional 
outcome. 
  Because of the heterogeneity of the obtained data, 
clinical results were summarized and expressed in Table 1 
for review by readers. 
REVIEW OF THE INCLUDED STUDIES 
 Maguire,  et al. [18] studied 5 knee arthroplasties with a 
patellar button performed in patients with kidney 
transplantation. All patients received perioperative 
cephalosporines. No complications were reported in this 
series and the authors found no reason to deny renal 
transplant patients the benefit of joint arthroplasty. However, 
no outcome index or information about patients’ follow up 
was provided. 
 Bradford,  et al. [19] reviewed the results in renal 
transplant recipients of 10 total knee arthroplasties in 6 
patients and 3 total shoulder arthroplasties in 2 patients. 
Most of these patients were young (mean age of 27 years). 
The indication of the arthroplasties was osteonecrosis 
presented as pain at mean of 19 months (2-71) post-
transplant. The patients received perioperative 
cephalosporines and corticosteroids when they got their 
arthroplasties. Of 6 patients presenting for total knee 
arthroplasty, 3 patients received 4 unicondylar knees while 
four patients received 6 bicondylar knees. On the other hand, 
the shoulder arthroplasties performed were of the Neer 
variety, two including glenoid components. The knee 
patients were followed up by the Kettlekamp score which 
improved from 55 to 100. In the shoulder patients, near 
normal function of motion with no joint pain were 
encountered. The authors found that the complications 
occurred in knee patients were few and minor compared to 
those affected the hip patients. The shoulder patients showed 
no complications. 
 Isono,  et al. [20] evaluated 10 cardiac transplant 
recipients who have had bilateral total hip arthroplasties (9 
patients) and bilateral knee arthroplasties (1 patient). The 
indication for the knee arthroplasties was osteonecrosis of 
the tibial plateaus. The patient received cephalosporin 
antibiotics perioperatively. The follow up of this patient 
revealed good range of motion of the operated knees with no 
report of any complication i.e. excellent outcome. 
Papagelopoulos,  et al. [21] studied the outcome of joint 
arthroplasty in a group orthotopic liver transplant recipients. 
This group included a 48 yr old patient with osteonecrosis of 
femoral and tibial condyles in one knee and a 39 yr old 
patient with post-traumatic osteoarthritis (OA) in one knee. 
These two patients were operated with cemented knee 
arthroplasties and the outcome was evaluated 3-6 years 
postoperatively using the Knee Society score. The evaluation 
showed an excellent outcome (improvement of the score 
from 45.5 to 94) with no signs of loosening or other 
complaints. Antibiotics prophylaxis with cephalosporins was 
used. 
  The authors believed that despite the high potential for 
complications, joint arthroplasties in orthotopic liver 
transplant recipients are considered safe and effective 
procedures. Tannenbaum, et al. [22] showed high risk of 
complications in a group renal and hepatic transplant 
recipients who underwent joint arthroplasties. Among them, 
there were 3 patients who were operated with knee prosthesis  
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(1 patient received double arthroplasties and 2 patients 
received single arthroplasty). The indications for the 
arthroplasty operations were osteonecrosis, non union of a 
supracondylar femoral fracture and OA. All patients received 
antibiotics prophylaxis with the first generation 
cephalosporins. The follow up of these patients was carried 
out using the Hospital for Special Surgery Knee score. The 
patient with osteonecrosis showed excellent results despite 
bilateral polyethelene wear of the tibial components. Another 
patient developed multi-organ failure after enterococcus 
infection and died. The last patient showed fair results after 
the knee arthroplasty operation. The authors alarmed for 
high rate of complications especially infections in this group 
of patients. 
  However, this study contained too few patients and the 
authors agreed that joint arthroplasties can provide an 
excellent functional outcome. They recommended better 
preventive measures and high index of suspicion to catch 
and treat early infections. 
  In a paper by Testa, et al. [23], the incidence and types of 
all surgical procedures in a group of liver transplant 
recipients was investigated and found the orthopaedic 
procedures to be the second most performed. Among these 
operations they reported no complications in 4 patients who 
underwent knee arthroplasties. The authors did not report the 
functional outcome in these patients. 
 Levitsky,  et al. [24] performed a retrospective analysis 
on liver transplant recipients who had joint arthroplasty at a 
single teaching institution between 1986 and 2002. Among 
the studied group, 8 knees and 1ankle were included. The 
indications for the joint arthroplasties were osteonecrosis in 
3 knees and 1 ankle and osteoarthritis in 5 knees. No 
complications were reported during or directly after the 
operations. The amount of blood loss, length of operation 
and length of hospital stay were similar to the arthroplasties 
done in healthy immuno-competent individuals. On long 
term follow up (50 months, 3-114); no signs of loosening, 
pain or decreased range of motion were detected. The 
authors concluded that joint arthroplasties may be safely and 
Table 1.  Summary of the Results of Joint Arthroplasties (other than the Hip) in Solid Organ Transplants 
 
Study  Number of 
Arthroplasties 
Indication and Time (mo) 
Post-Transplant for 
Arthroplasty 
Mean Age or 
Age (yr) at 
Arthroplasty 
Mean 
Follow-Up 
(mo) 
Outcome  Complications 
Maguire et al. 
[18] 
5 knees  Osteonecrosis 
N/A 
N/A  N/A  N/A  None 
Bradford et al. 
[19] 
10 knees 
(6 patients) 
3 shoulder 
(2 patients) 
 
Osteonecrosis 
42 (10-175) 
34 (16-56)  12-108  Kettle-kamp 
Knee score: 
(37  72) 
Shoulder: 
No pain 
Near normal 
function 
Conversion of uni- to total 
knee prosthesis (n=1) 
Pin extrusion (n=1) 
Stiffness (n=1) 
Isono 
et al. [20] 
2 knees 
(1 patient) 
Osteonecrosis, 
(38) 
34  34 (3-105)  N/A 
 
None 
Papagel-
opoulos 
et al. [21] 
2 knees 
(2 patients) 
Osteonecrosis, (48) 
Posttraumatic OA, (39) 
39, 64  36-72  Knee Society 
Score 
(45.5  94) 
None 
Tannen-baum 
et al. [22] 
4 knees 
(3 patients) 
Osteonecrosis, 
supracondylar fracture, OA 
(36-72) 
43, 45, 46, 67  12-120  Hospital for 
Special 
Surgeries 
Knee score 
PE wear (n=1) 
Infection  death (n=1) 
Testa 
et al. [23] 
4 knees  N/A 
53 (39-70) 
N/A  N/A  N/A  None 
Levitsky et al. 
[24] 
 
8 knees 
(5 patients) 
1 ankle 
(1 patient) 
Osteonecrosis, OA 
(23-74) 
44 (39-59)  50 (3-114)  N/A  No major complications 
Mild wound bleeding 
(n=1) 
Sperling et al. 
[25] 
 
5 shoulders 
(4 patients) 
Osteonecrosis, 
Malunion, OA, 
42 (6-71) 
55 (41-79)  65 (26-202  Modified 
Neer rating 
Superior subluxation 
(n=1) 
Glenoidal radiolucency 
(n=1) 
Boquet et al. 
[26]  
16 knees 
(12 patients) 
Osteonecrosis, OA, RA 
132 (10-294) 
58 (32-70)  65 (25-107)  Knee Society 
Score= 97.1 
(93-100) 
Scar necrosis (n=1) 
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successfully performed in liver transplant recipients. They 
recommended larger randomized prospective studies to 
confirm their results and to make a statistical comparison 
with arthroplasties performed in healthy individuals. 
  In a small case series reporting the outcome of 5 shoulder 
arthroplasties in 4 solid organ transplant recipients (2 renal, 1 
hepatic and 1 lung), Sperling and Cofield [25] 
retrospectively reviewed a minimum of 2 years (mean 5.4 
years) results using a modified Neer result rating system. 
The indications of the arthroplasties were osteonecrosis in 3 
shoulders (received hemi-arthroplasty), osteoarthritis in 1 
(received total shoulder arthroplasty) and malunion in 1 
(received total shoulder arthroplasty). Standard antibiotics 
prophylaxis was given perioperatively. No other preparations 
were carried out. The authors found 4 excellent results (no or 
slight pain with at least 140º active elevation and 45º 
external rotation) and one satisfactory result (no to moderate 
pain with at least 90º active elevation and 20º external 
rotation). No infections or loosening requiring revision 
surgeries were reported. However, the authors believed that 
additional follow up was necessary to determine whether the 
long term results would be comparable to results of patients 
without transplant surgery. 
  The most recent paper concerning outcome evaluation of 
joint arthroplasties in solid organ transplant recipients is 
published this year in by Boquet, et al. [26]. In this work, the 
outcome of 16 knee arthroplasties in 12 renal transplant 
recipients (mean age of 58 years) was evaluated using the 
Knee Society score and the Knee Society Total Knee 
Arthroplasty Roentgenographic evaluation. The indications 
of the arthroplasties were femoral condyle osteonecrosis in 6 
knees, tibial plataue osteonecrosis in 1 knee, osteoarthritis in 
7 knees and rheumatoid arthritis in 2 knees. The patients 
were followed up for 65 months (25-107). The authors found 
excellent clinical results with mean knee score of 97.1 (93-
100) and mean function score of 87.7 (60-100). The 
radiological evaluation showed no signs of loosening, 
osteolysis or malposition of the operated components. This 
series of patients showed no postoperative infections ot other 
major complications. One patient developed scar necrosis 
which warranted surgical repair and 1 patient died 8 years 
after the arthroplasty operation secondary to mitral valve 
endocarditis and septicaemia unrelated to the knee surgery. 
Once again, the authors emphasized the importance of longer 
term follow up studies to confirm the excellent results found 
in this report. 
CONCLUSION 
  Solid organ transplantation is a life-saving operation and 
transplant patients are unique in many aspects. Many are 
young and have no previous joint diseases. When these 
patients develop osteonecrosis with rapid functional 
deterioration, joint arthroplasty may restore joint function. 
On the other hand, patients can be elderly and have advanced 
bone disease. In the later case, joint arthroplasty may be 
accompanied by increased risk for mechanical failure. 
  Despite the theoretical risks of high infection rates and 
inferior bone quality associated with joint arthroplasties in 
solid organ transplant recipients, the present review shows 
good to excellent results of knee, shoulder and ankle 
replacements performed in patients with renal, hepatic, 
cardiac or lung transplantation. No special perioperative 
preparations seem necessary. Antibiotics and thrombosis 
prophylaxis should be given as in standard arthroplasty 
operations. The relatively young age of patients (mean 49 
years) should be considered when choosing the type of 
implants and the method of fixation. High index of suspicion 
is essential to catch early infections which should be 
managed rigorously. 
  As recommended by most of the papers included in this 
review, larger prospective studies and long term follow up 
are needed to determine the safety and outcome of these 
surgeries in comparison to standard joint arthroplasties done 
in healthy individuals. 
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